Sanara MedTech Inc. — Director's Dealing 2022

Jun 30, 2022

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: Sanara MedTech Inc. (SMTI)
CIK: 0000714256
Period of Report: 2022-06-28

Reporting Person: Fleming Zachary B. (Chief Executive Officer)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2022-06-28	Common Stock	S	69	$21.00	Disposed	39244	Direct
2022-06-29	Common Stock	S	294	$21	Disposed	38950	Direct

Footnotes

F1: The transaction reported in this Form 4 was effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on June 3, 2022.